イシダ　ヒデキ   Ishida Hideki   石田　英樹    所属   医学部 医学科（東京女子医科大学病院）    職種   教授
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.
掲載誌名	正式名：Japanese journal of clinical oncology 略　 称：Jpn J Clin Oncol ISSNコード：14653621/03682811
掲載区分	国外
巻・号・頁	49(6),pp.576-580
著者・共著者	YOSHIDA Kazuhiko†*, TAKAGI Toshio, KONDO Tsunenori, KOBAYASHI Hirohito, IIZUKA Junpei, FUKUDA Hironori, ISHIHARA Hiroki, OKUMI Masayoshi, ISHIDA Hideki, TANABE KAZUNARI
発行年月	2019/06
概要	We reviewed the clinical efficacy of axitinib after nivolumab treatment failure in six patients with metastatic renal cell carcinoma (RCC); the patients had received nivolumab treatment following vascular endothelial growth factor receptor (VEGFR) inhibitors. Most had undergone radical nephrectomy; five had clear-cell carcinoma and acquired cystic disease-associated carcinoma. The patients were finally diagnosed with progressive disease during nivolumab treatment. Immediately after nivolumab treatment failure, one patient receiving pazopanib had an adverse event soon after, and subsequently received axitinib, which the others received. The size of the metastatic tumors treated with axitinib after nivolumab was on average 33.9% smaller. Following treatment, three patients experienced partial response with remarkable tumor shrinkage and three had stable disease (SD), of which most maintained for >5 months. One patient with SD died from gradual tumor progression after axitinib treatment. Axitinib treatment after nivolumab treatment failure can be beneficial for some patients with metastatic RCC.
DOI	10.1093/jjco/hyz040
PMID	30924496